The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
H.H. Sheikh Mohamed hosts Eid Al Adha reception for UAE Rulers
UAE President awards UK ambassador First Class Order of Independence
UAE President, Emir of Kuwait exchange Eid Al-Adha greetings during phone call
UAE President wishes 'prosperity to all' in Eid greeting
UAE President performs Eid Al Adha prayer at Sheikh Zayed Grand Mosque
UAE, Australia discuss trade, security and stability during official visit
UN Security Council condemns drone attack on Barakah Nuclear Power Plant
UAE President awards Irish ambassador First Class Order of Zayed II
